World Asset Management Inc Sells 343 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

World Asset Management Inc decreased its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) by 4.5% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 7,273 shares of the medical research company’s stock after selling 343 shares during the quarter. World Asset Management Inc’s holdings in Thermo Fisher Scientific were worth $3,669,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in TMO. Viking Global Investors LP lifted its position in Thermo Fisher Scientific by 1,007.6% in the 1st quarter. Viking Global Investors LP now owns 861,887 shares of the medical research company’s stock valued at $393,348,000 after acquiring an additional 784,070 shares in the last quarter. Morgan Stanley lifted its position in Thermo Fisher Scientific by 7.3% in the 1st quarter. Morgan Stanley now owns 8,293,242 shares of the medical research company’s stock valued at $3,784,871,000 after acquiring an additional 566,814 shares in the last quarter. Flossbach Von Storch AG lifted its position in Thermo Fisher Scientific by 130.6% in the 2nd quarter. Flossbach Von Storch AG now owns 796,673 shares of the medical research company’s stock valued at $401,898,000 after acquiring an additional 451,134 shares in the last quarter. Alliancebernstein L.P. lifted its position in Thermo Fisher Scientific by 60.9% in the 1st quarter. Alliancebernstein L.P. now owns 956,561 shares of the medical research company’s stock valued at $436,555,000 after acquiring an additional 361,897 shares in the last quarter. Finally, Alecta Pensionsforsakring Omsesidigt increased its stake in Thermo Fisher Scientific by 31.0% in the 2nd quarter. Alecta Pensionsforsakring Omsesidigt now owns 1,373,000 shares of the medical research company’s stock valued at $692,637,000 after buying an additional 325,000 shares during the last quarter. 85.50% of the stock is currently owned by institutional investors and hedge funds.

In other Thermo Fisher Scientific news, Director Jim P. Manzi sold 572 shares of the business’s stock in a transaction on Friday, July 30th. The shares were sold at an average price of $536.54, for a total value of $306,900.88. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Marc N. Casper sold 10,000 shares of the business’s stock in a transaction on Wednesday, August 4th. The stock was sold at an average price of $539.05, for a total transaction of $5,390,500.00. The disclosure for this sale can be found here. Insiders own 0.44% of the company’s stock.

Several equities research analysts have commented on TMO shares. The Goldman Sachs Group decreased their price objective on shares of Thermo Fisher Scientific from $590.00 to $530.00 and set a “buy” rating for the company in a research note on Tuesday, June 15th. They noted that the move was a valuation call. Robert W. Baird increased their price objective on shares of Thermo Fisher Scientific from $545.00 to $550.00 and gave the company an “outperform” rating in a research note on Wednesday, June 23rd. Zacks Investment Research lowered shares of Thermo Fisher Scientific from a “hold” rating to a “strong sell” rating and set a $491.00 price objective for the company. in a research note on Monday, July 12th. BTIG Research raised their price target on shares of Thermo Fisher Scientific from $590.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, July 29th. Finally, Benchmark assumed coverage on shares of Thermo Fisher Scientific in a research note on Friday, July 16th. They set a “buy” rating and a $580.00 price target for the company. One research analyst has rated the stock with a sell rating, two have given a hold rating and eighteen have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $547.95.

NYSE:TMO traded down $0.32 during trading hours on Wednesday, hitting $562.08. The stock had a trading volume of 12,521 shares, compared to its average volume of 1,587,995. The company has a 50 day simple moving average of $542.01 and a two-hundred day simple moving average of $494.08. The company has a debt-to-equity ratio of 0.51, a current ratio of 2.78 and a quick ratio of 2.11. Thermo Fisher Scientific Inc. has a one year low of $412.80 and a one year high of $575.63. The firm has a market capitalization of $221.13 billion, a price-to-earnings ratio of 26.07, a P/E/G ratio of 1.33 and a beta of 0.74.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings results on Wednesday, July 28th. The medical research company reported $5.60 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $5.51 by $0.09. Thermo Fisher Scientific had a net margin of 22.47% and a return on equity of 29.43%. Equities research analysts anticipate that Thermo Fisher Scientific Inc. will post 22.07 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 15th. Stockholders of record on Wednesday, September 15th will be issued a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.19%. The ex-dividend date of this dividend is Tuesday, September 14th. Thermo Fisher Scientific’s dividend payout ratio is currently 5.32%.

About Thermo Fisher Scientific

Thermo Fisher Scientific, Inc engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Further Reading: Average Daily Trade Volume Explained

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.